Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03736629 · ClinicalTrials.gov registry record · Phase 2
Azithromycin Treatment for the Airway Microbiome in Asthma
A Phase 2 study, sponsored by University of Chicago.
- Terminated
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
NCT03736629 is a Phase 2 study that was terminated before completion, run by University of Chicago. The registered enrollment target is 17 participants.
The verdict
NCT03736629, a Phase 2 study, was terminated before completion, sponsored by University of Chicago.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study to determine whether the bacteria inside the lungs of people with asthma can be modified (changed) if they are given an antibiotic and if this change is associated with an improvement in asthma symptoms.
Interventions
- DRUG Placebo
- DRUG Azithromycin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2019-02-01 |
| Est. Completion | 2022-06-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03736629
The ClinicalTrials.gov registry entry for NCT03736629 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03736629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03736629 about?
NCT03736629 is a clinical study titled "Azithromycin Treatment for the Airway Microbiome in Asthma". The purpose of this study to determine whether the bacteria inside the lungs of people with asthma can be modified (changed) if they are given an antibiotic and if this change is associated with an improvement in asthma symptoms.
What is the current status of trial NCT03736629?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2019-02-01. Estimated completion is 2022-06-01.
What interventions are being tested in trial NCT03736629?
The interventions under investigation include: Placebo (DRUG), Azithromycin (DRUG).
Who is sponsoring clinical trial NCT03736629?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.